NCT02985567

Brief Summary

The study involves a prospective evaluation of chloral hydrate sedation for the measurement of intraocular pressure in children ages one month to five years of age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 30, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 7, 2016

Completed
Last Updated

December 7, 2016

Status Verified

December 1, 2016

Enrollment Period

3.2 years

First QC Date

November 30, 2016

Last Update Submit

December 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in intraocular pressure during chloral hydrate sedation

    Unit- mmHg

    25 minutes after sedation to 125 minutes after sedation

Secondary Outcomes (6)

  • Chloral hydrate dose required for successful sedation

    Adminstration to adequate sedation (up to 30 minutes)

  • Time to recovery

    Sedation induction to 125 minutes after sedation

  • Hear rate under sedation

    Sedation induction to 125 minutes after sedation

  • Blood pressure under sedation

    Sedation induction to 125 minutes after sedation

  • Oxygen saturation under sedation

    Sedation induction to 125 minutes after sedation

  • +1 more secondary outcomes

Study Arms (2)

Intraocular pressure evaluation

Intraocular pressure evaluation using Icare tonometer 25 minutes after sedation, and then every 10 minutes until sedation is complete

Other: Intraocular pressure evaluation

Safety of sedation

Documentation of: 1. The need for repeat dosing of chloral hydrate. 2. The level of alertness of the patient at the end of sedation and the total time between induction and readiness for discharge 3. Interventions required for the patient including administration of oxygen, and need for intubation.

Interventions

Intraocular pressure checked with Icare rebound tonometer at 25 minutes after induction, followed by every 10 minutes until sedation was complete.

Intraocular pressure evaluation

Eligibility Criteria

Age1 Month - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children aged 1 month to five years requiring sedation for ophthalmic care at King Khaled Eye Specialist Hospital (KKESH).

You may qualify if:

  • ages 1 month to five years
  • require sedation for ophthalmic care

You may not qualify if:

  • weight \<3 kg or \>20 kg
  • infection/ocular surface disease
  • medical contraindication of chloral hydrate
  • green or gray nasal discharge
  • fever, productive cough, chest retractions, or other signs of respiratory infection
  • oxygen saturation \< 90%
  • active infectious disease such as rubella or varicella
  • rectal or tympanic temperature \> 37.7 degrees, or oral or temporal artery temperature \> 37.2 degrees
  • history of current ongoing vomiting and diarrhea
  • anemia (Hgb \< 9.0mg),
  • history of seizure in past 6 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Khaled Eye Specialist Hospital (KKESH)

Riyadh, Riyadh Region, 12329, Saudi Arabia

Location

Related Publications (2)

  • Vade A, Sukhani R, Dolenga M, Habisohn-Schuck C. Chloral hydrate sedation of children undergoing CT and MR imaging: safety as judged by American Academy of Pediatrics guidelines. AJR Am J Roentgenol. 1995 Oct;165(4):905-9. doi: 10.2214/ajr.165.4.7676990.

    PMID: 7676990BACKGROUND
  • Litman RS, Soin K, Salam A. Chloral hydrate sedation in term and preterm infants: an analysis of efficacy and complications. Anesth Analg. 2010 Mar 1;110(3):739-46. doi: 10.1213/ANE.0b013e3181ca12a8. Epub 2009 Dec 23.

    PMID: 20032023BACKGROUND

Study Officials

  • David S Friedman, MD, MPH, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 30, 2016

First Posted

December 7, 2016

Study Start

September 1, 2013

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

December 7, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations